Healthy Skepticism Library item: 6873

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mansour P.
More lessons from unfortunate events in Toronto.
Lancet 1999 May 29; 353:(9167):1888

Abstract:

Since clinical trials of new drugs cannot proceed without research ethics committee approval, these committees should simply make it a condition of approval that the investigators have the freedom to inform their patients of, and if necessary to publish, any concern they have about the drug without the threat of legal action being taken against them.

Keywords:
*letter to the editor/ Research Ethics Boards/ reporting of results/ relationship between researchers, academic institutions and industry/ drug company sponsored research/ETHICAL ISSUES IN PROMOTION: ETHICS OF TRIALS/SPONSORSHIP: RESEARCH Clinical Trials Drug Industry* Ethics, Medical* Humans Iron Chelating Agents Ontario Pyridones Safety